Putnam Investments LLC Theravance Biopharma, Inc. Transaction History

Putnam Investments LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$9.65 - $11.34 $521 - $612	-54 Reduced 0.05%	102,102 $1.15 Million
Q3 2022 Nov 14, 2022	SELL	$8.39 - $10.22 $15,538 - $18,927	-1,852 Reduced 1.78%	102,156 $1.04 Million
Q2 2022 Aug 15, 2022	SELL	$8.41 - $10.34 $10,815 - $13,297	-1,286 Reduced 1.22%	104,008 $943,000
Q1 2022 May 16, 2022	BUY	$8.33 - $12.96 $877,099 - $1.36 Million	105,294 New	105,294 $1.01 Million

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $629M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.